1. Home
  2. WFRD vs GRFS Comparison

WFRD vs GRFS Comparison

Compare WFRD & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weatherford International plc

WFRD

Weatherford International plc

HOLD

Current Price

$92.60

Market Cap

6.0B

Sector

Industrials

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.20

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFRD
GRFS
Founded
1941
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.8B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
WFRD
GRFS
Price
$92.60
$8.20
Analyst Decision
Buy
Hold
Analyst Count
8
2
Target Price
$97.50
$10.15
AVG Volume (30 Days)
1.1M
646.0K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
1.19%
1.74%
EPS Growth
N/A
N/A
EPS
5.93
N/A
Revenue
$4,331,000,000.00
N/A
Revenue This Year
$0.37
$5.33
Revenue Next Year
$3.48
$6.50
P/E Ratio
$15.56
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$36.74
$6.19
52 Week High
$110.57
$11.14

Technical Indicators

Market Signals
Indicator
WFRD
GRFS
Relative Strength Index (RSI) 39.83 32.64
Support Level $82.22 $7.64
Resistance Level $106.38 $9.11
Average True Range (ATR) 3.77 0.30
MACD -2.16 -0.09
Stochastic Oscillator 26.82 1.50

Price Performance

Historical Comparison
WFRD
GRFS

About WFRD Weatherford International plc

Weatherford provides oilfield services and equipment to national, integrated, public, and private oil and gas operators. It operates across multiple upstream markets, including offshore, the rest of the world onshore, and US onshore, where Weatherford has limited exposure. The Middle East, North Africa, and Asia account for over 25% of sales. Weatherford also offers manufacturing, research, and training services. Performance is reported through three segments: drilling and evaluation, well construction and completions, and production and intervention.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: